Systems, methods and devices for paired plasticity

Information

  • Patent Grant
  • 11116933
  • Patent Number
    11,116,933
  • Date Filed
    Tuesday, April 25, 2017
    7 years ago
  • Date Issued
    Tuesday, September 14, 2021
    3 years ago
Abstract
Systems, methods and devices for paired training include timing controls so that training and neural stimulation can be provided simultaneously. Paired trainings may include therapies, rehabilitation and performance enhancement training. Stimulations of nerves such as the vagus nerve that affect subcortical regions such as the nucleus basalis, locus coeruleus or amygdala induce plasticity in the brain, enhancing the effects of a variety of therapies, such as those used to treat tinnitus, stroke, traumatic brain injury and post-traumatic stress disorder.
Description
BACKGROUND

The present disclosure relates generally to therapy, rehabilitation and training including induced plasticity. More particularly, the disclosure relates to methods and systems of enhancing therapy, rehabilitation and training using nerve stimulation paired with training experiences.


SUMMARY

For purposes of summarizing the invention, certain aspects, advantages, and novel features of the invention have been described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment of the invention. Thus, the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.





BRIEF DESCRIPTION OF THE DRAWINGS

The disclosed inventions will be described with reference to the accompanying drawings, which show important sample embodiments of the invention and which are incorporated in the specification hereof by reference, wherein:



FIG. 1 is a block diagram depicting a paired training system, in accordance with an embodiment;



FIG. 2 is a block diagram depicting a paired training system affecting a sub-cortical region, in accordance with an embodiment;



FIG. 3 is a block diagram depicting a paired training system affecting the nucleus basalis, in accordance with an embodiment;



FIG. 4 is a block diagram depicting a paired training system affecting the locus coeruleus, in accordance with an embodiment;



FIG. 5 is a block diagram depicting a paired training system affecting the amygdala, in accordance with an embodiment;



FIG. 6 is a block diagram depicting a paired training system affecting the nucleus of the solitary tract (NTS), in accordance with an embodiment;



FIG. 7 is a block diagram depicting a paired training system affecting the cholinergic system, in accordance with an embodiment;



FIG. 8 is a block diagram depicting a paired training system affecting the noradrenergic system, in accordance with an embodiment;



FIG. 9 is a simplified diagram depicting a stimulator, in accordance with an embodiment;



FIG. 10 is a simplified diagram depicting a wireless stimulator, in accordance with an embodiment;



FIG. 11 is a simplified diagram depicting a dual stimulator configuration, in accordance with an embodiment;



FIG. 12 is a simplified diagram depicting a multi-stimulator configuration, in accordance with an embodiment;



FIG. 13 is a graph depicting a constant current stimulation pulse, in accordance with an embodiment;



FIG. 14 is a graph depicting an exponential stimulation pulse, in accordance with an embodiment;



FIG. 15 is a graph depicting a train of constant current stimulation pulses, in accordance with an embodiment;



FIG. 16 is a block diagram depicting a synchronizing control system, in accordance with an embodiment;



FIG. 17 is a graph depicting synchronized pairing, in accordance with an embodiment;



FIG. 18 is a block diagram depicting a response control system, in accordance with an embodiment;



FIG. 19 is a graph depicting response pairing, in accordance with an embodiment;



FIG. 20 is a block diagram depicting a manual control system, in accordance with an embodiment;



FIG. 21 is a graph depicting manual pairing, in accordance with an embodiment;



FIG. 22 is a block diagram depicting a closed loop control system, in accordance with an embodiment;



FIG. 23 is a graph depicting closed loop pairing, in accordance with an embodiment;



FIG. 24 is a block diagram depicting an initiated control system, in accordance with an embodiment;



FIG. 25 is a graph depicting initiated pairing, in accordance with an embodiment;



FIG. 26 is a block diagram depicting a delayed response timing control system, in accordance with an embodiment; and



FIG. 27 is a graph depicting delayed response pairing, in accordance with an embodiment.





DETAILED DESCRIPTION OF THE DRAWINGS

The numerous innovative teachings of the present application will be described with particular reference to presently preferred embodiments (by way of example, and not of limitation). The present application describes several inventions, and none of the statements below should be taken as limiting the claims generally. Where block diagrams have been used to illustrate the invention, it should be recognized that the physical location where described functions are performed are not necessarily represented by the blocks. Part of a function may be performed in one location while another part of the same function is performed at a distinct location. Multiple functions may be performed at the same location.


With reference to FIG. 1, a paired training system is shown. A timing control system 106 is communicably connected to a neural stimulator system 108 and a training system 110. Receiving timing instruction from the timing control system 106, the neural stimulator system 108 provides stimulation to a nerve 104. Similarly receiving timing instruction from the timing control system 106, or providing timing instruction to the timing control system, the training system 110 generates desired mental images, ideas, formations or states in the brain 102. The stimulation of the nerve 104 affects the brain 102 by inducing plasticity. The temporally paired combination of training and stimulation generates manifestations of plasticity in the brain 102 that may be measured by a plasticity measure system 112.


The timing controls system 106 generally provides the simultaneous nature of the pairing. The stimulation and the training are simultaneous in that they occur at the same time, that is, there is at least some overlap in the timing. In some embodiments, the stimulation may lead the start of the training while in other embodiments, the stimulation may follow the start of the training. In many cases, the stimulation is shorter in duration than the training, such that the stimulation occurs near the beginning of the training. Plasticity resulting from stimulation has been shown to last minutes or hours, so a single stimulation pulse may suffice for the whole duration of extended training.


In the treatment of tinnitus, for example, the training may consist of brief audible sounds including selected therapeutic frequencies, paired with stimulations. Because the duration of the sounds may be short, the timing may be controlled very precisely so that the sound coincides temporally with the stimulation. This kind of precision may typically require some form of computer control. In other forms of rehabilitation or education, the timing of the training and/or the stimulation may be controlled manually. Further therapies and training may include training triggered timing or physical condition feedback to provide a closed-loop system.


The neural stimulation system 108 may provide stimulation of the nerve 104 using electrical stimulation, chemical stimulation, magnetic stimulation, optical stimulation, mechanical stimulation or any other form of suitable nerve stimulation. In accordance with an embodiment, an electrical stimulation is provided to the left vagus nerve. In an electrical stimulation system, suitable stimulation pulses may include a variety of waveforms, including constant current pulses, constant voltage pulses, exponential pulses or any other appropriate waveform. An electrical stimulation system may use a single stimulation pulse or a train of stimulation pulses to stimulate the nerve 104. Stimulation parameters are selected to affect the brain 102 appropriately, with reference to the affected brain regions or systems, plasticity measures, desynchronization or any other appropriate stimulation parameter measure. A half second train of biphasic stimulation pulses, with a pulse width of 100 microseconds, at 0.8 milliamps and at 30 Hz has been used effectively in the treatment of tinnitus.


Paired stimulation could be accomplished using deep brain stimulation, cortical stimulation, transcranial magnetic stimulation and any other suitable neural stimulation.


One indication of appropriate stimulation may be desynchronization of the cortical EEG. A 0.8 milliamp pulse has been shown to cause cortical desynchronization at frequencies between 30 and 150 Hz. 0.4 milliamp pulses desynchronize the cortex at higher frequencies of 100 to 150 Hz. Desynchronization has been shown to last for at least four seconds in response to stimulation of the vagus nerve.


The simultaneous training system 110 generates the sensory input, motor sequences, cognitive input, mental images, ideas, formations or states that are to be retained by the brain 102. A training system 110 may provide sensory information, such as visual, auditory, olfactory, tactile or any other suitable sensory information. Training system 110 may include physical therapies, cognitive therapies, emotional therapies, chemical therapies, or any other suitable therapies. Training system 110 may present educational information. Training system 110 may include the subject, physically, mentally, emotionally or in any other suitable fashion. Training system 110 may include teachers, doctors, therapists, counselors, instructors, coaches or any other suitable training provider. Training system 110 may evoke specific patterns of neural activity by direct brain stimulation, for example by electrical, magnetic, optical, or any other suitable pattern evocation systems. Training system 110 may inactivate specific brain regions via chemical agents, cooling, magnetic stimulation, or other suitable methods.


The paired training system of FIG. 1 affects the brain 102 to generate plasticity that can be measured by a plasticity measure system 112. In the treatment of tinnitus, a cortical map may be used to measure the map distortion and correction that accompanies the successful treatment of tinnitus. Less invasively, the plasticity can be measured by behaviorally reactions to stimuli, such as a startle test for tinnitus. Further, plasticity can be measured by inquiring about the subjective experience of a subject. If a tinnitus patient no longer experiences a persistent noise, plasticity has been measured.


With reference to FIG. 2, a paired training system affecting a subcortical region 114 of the brain 102, in accordance with an embodiment is shown. The stimulation of nerve 104 affects a subcortical region 114. The subcortical region 114, in turn, affects the brain to induce plasticity. Stimulation of nerves 104 such as the trigeminal nerve and other cranial nerves are known to affect the subcortical region 114.


With reference to FIG. 3, a paired training system affecting the nucleus basalis 116, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the nucleus basalis 116. The nucleus basalis, in turn, affects the brain 102 to induce plasticity.


With reference to FIG. 4, a paired training system affecting the locus coeruleus 118, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the locus coeruleus 118. The locus coeruleus 118, in turn, affects the brain 102 to induce plasticity.


With reference to FIG. 5, a paired training system affecting the amygdala 120, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the amygdala 120. The amygdala 120, in turn, affects the brain 102 to induce plasticity.


With reference to FIG. 6, a paired training system affecting the NTS 122, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the NTS 122. The NTS 122, in turn, affects the brain 102 to induce plasticity.


With reference to FIG. 7, a paired training system affecting the cholergenic system 124, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the cholergenic system 124. The cholergenic system 124 releases acetylcholine (ACh) into the brain 102 inducing plasticity.


With reference to FIG. 8, a paired training system affecting the noradrenergic system 126, in accordance with an embodiment, is shown. The stimulation of nerve 104 affects the noradrenergic system 126. The noradrenergic system 126 releases noradrenaline (NE) into the brain 102 inducing plasticity.


With reference to FIG. 9, a neural stimulator system, in accordance with an embodiment, is shown. A neural stimulator control 109 is communicably connected to a neurostimulator 128. Neurostimulator 128 provides a stimulation pulse to a nerve 104 via a pair of electrodes 130a and 130b. Electrodes 103a and 130b could be cuff electrodes, conductive plates or any other suitable neural stimulation electrode. The neurostimulator may be powered by a piezoelectric powering system as well as near field inductive power transfer, far-field inductive power transfer, battery, rechargeable battery or any other suitable neurostimulator power system. When neural stimulator control 109 receives timing instructions from a timing control system (not shown), the neural stimulator control 109 initiates a stimulation pulse from the neurostimulator 128 via electrodes 130a and 130b.


With reference to FIG. 10, a wireless neural stimulator system, in accordance with an embodiment is shown. Neurostimulator 128 communicates with the neural stimulation system 109 using an inductive transponder coil 132. The neural stimulator system 109 includes an external coil 134. Information may be communicated between the neural stimulator system 109 and the neurostimulator 128. Power may be transferred to the neurostimulator 128 by the neural stimulator system.


With reference to FIG. 11, a dual neurostimulator system, in accordance with an embodiment, is shown. Two neurostimulators 128 may stimulate neural 104. The neurostimulators may be controlled to reinforce each other, as redundancy, or to prevent efferent signals from projecting away from the brain.


With reference to FIG. 12, a multi-neurostimulator system, in accordance with an embodiment, is shown. A plurality of neurostimulators 128 may stimulate nerve 104. The neurostimulators may be controlled to reinforce each other, as redundancy, or to prevent efferent signals from projecting away from the brain.


With reference to FIG. 13, a graph shows a constant current stimulation pulse, in accordance with an embodiment.


With reference to FIG. 14, a graph shows an exponential stimulation pulse, in accordance with an embodiment.


With reference to FIG. 15, a graph shows a train of constant current stimulation pulses, in accordance with an embodiment.


With reference to FIG. 16, a synchronized timing control system, in accordance with an embodiment, is shown. The synchronized timing control system includes a synchronizing timing control 186. The synchronizing timing control 186 is communicably connected to the neural stimulation system 108 and the training system 110. The synchronizing timing control 136 provides timing instructions to the neural stimulation system 108 and the training system 110 so that the stimulation and training occur simultaneously. In the treatment of tinnitus, the stimulation of the nerve may slightly precedes each training sound, to give the stimulation time to affect the brain when the training sound is presented. Further embodiments may include other suitable timing variations.


With reference to FIG. 17, a graph shows a possible timing relationship between event and stimulation for a synchronized timing control system.


With reference to FIG. 18, a response timing control system, in accordance with an embodiment, is shown. The response timing control system includes a response timing control 138. The response timing control 138 is communicably connected to the neural stimulation system 108 and a simultaneous event monitor 140. The response timing control 138 receives timing instructions from the event monitor 140 and provides timing instructions to the neural stimulation system 108, so that the stimulation and training occur simultaneously. Because the stimulation is generated in response to an event, the stimulation will generally lag the event by some finite time delta t. In cases where there is an event precursor that can be monitored, the timing can be made more exact.


With reference to FIG. 19, a graph shows a possible timing relationship between a monitored event and a nerve stimulation.


With reference to FIG. 20, a manual timing control system, in accordance with an embodiment, is shown. The manual timing control system includes a response timing control 138. The response timing control 138 is communicably connected to the neural stimulation system 108 and a manual input 142. The response timing control 138 receives timing instructions from the manual input 142 and provides timing instructions to the neural stimulation system 108, so that the stimulation and training occur simultaneously.


With reference to FIG. 21, a graph shows a possible timing relationship between an event, a manual input and a neural stimulation.


With reference to FIG. 22, a closed loop timing control system, in accordance with an embodiment, is shown. The closed loop timing control system includes a closed loop timing control 144. The closed loop timing control 138 is communicably connected to the neural stimulation system 108 and a sensor 146. The closed loop timing control 144 receives timing instructions from the sensor 146 and provides timing instructions to the neural stimulation system 108, so that the stimulation and training occur simultaneously.


With reference to FIG. 23, a graph shows a possible timing relationship between an sensed training event and a neural stimulation is shown.


Sensor 146 may monitor external or internal events, including heart-rate, blood pressure, temperature, chemical levels or any other parameter that may indicate a training event.


With reference to FIG. 24, a initiated timing control system, in accordance with an embodiment, is shown. The initiated timing control system includes an initiated timing control 148. The initiated timing control 148 is communicably connected to a neural stimulation system 106 and an event generator 150. The initiated timing control 148 receives timing information from the neural stimulation system 106, indicating that a nerve has been stimulated. The initiated timing control 148 provides timing instructions to the event generator 150, such as a therapeutic sound generator connected by Bluetooth, such that the event generator 150 generates an event during the stimulation pulse.


With reference to FIG. 25, a graph shows a possible timing relationship between a neural stimulation and an event generation.


With reference to FIG. 26, a delayed response timing control system, in accordance with an embodiment, is shown. The delayed response timing control system includes an delayed response timing control 152. The delayed response timing control 152 is communicably connected to a neural stimulation system 106 and a preliminary event sensor 154. The preliminary event sensor 154 detects a preliminary event that anticipates a pairing event The delayed response timing control 148 receives timing information from the preliminary event sensor 154, indicating that a preliminary event has been detected. The delay response timing control 148 provides timing instructions to the neural stimulation system 106 to initiate nerve stimulation. In the depicted embodiment, the timing control 152 initiates the stimulation before the beginning of the pairing event, giving a negative delta t. A delay response timing system may initiate stimulation at the same time as the beginning of the pairing event, or after the beginning of the pairing event.


With reference to FIG. 27, a graph shows a possible timing relationship between a neural stimulation, a preliminary event and a pairing event.


The plasticity induced by neural stimulation can be paired with a variety of therapies, rehabilitation, training and other forms of personal improvement. Each therapy acts as a training source. The specific timing requirements associated with each therapy are derived from the specifics of the therapy, such that the stimulation occurs during the training, and most effectively near the beginning of the training. Some possible therapies may include behavioral therapies such as sensory discrimination for sensory deficits, motor training for motor deficits, with or without robotic assistance and cognitive training/rehabilitation for cognitive deficits. Exercise and motor therapy could be paired to treat motor deficits arising from traumatic brain injury, stroke or Alzheimer's disease and movement disorders. Constraint induced therapy could be paired to help prevent the use of alternative strategies in order to force use of impaired methods. Speech therapy could be paired for speech and language deficits. Cognitive therapies could be paired for cognitive problems.


Sensory therapies, such as tones, could be paired to treat sensory ailments such as tinnitus. In treating tinnitus, the paired tones may be at frequencies distinct from the frequencies perceived by the tinnitus patient.


Exposure or extinction therapy could be paired to treat phobias or post-traumatic stress disorder.


Computer-based therapies such as FastForward for dyslexia, Brain Fitness Program Classic or Insight, could be paired to enhance their effects. Psychotherapy could be paired, as well as other therapeutic activities in the treatment of obsessive-compulsive disorder, depression or addiction.


Biofeedback therapy could be paired. For example, temperature readings or galvanic skin responses could be paired to treat anxiety or diabetes. An electromyograph could be paired to improve motor control after brain spinal or nerve damage. A pneumograph could be paired to improve breathing control in a paralyzed patient. A real-time fMRI could be paired to improve pain control or treat OCD. An electrodermograph, EEG, EMG or electrocardiograph could be paired to treat disorders such as anxiety. An electroencephalograph could be paired to treat epilepsy. An hemoencephalography could be paired to treat migraines. A photoplethysmograph could be paired to treat anxiety. A capnometer could be paired to treat anxiety. Virtual reality therapy could be paired to treat disorders such as addiction, depression, anxiety or posttraumatic stress disorder. Virtual reality therapy could also be paired to enhance cognitive rehabilitation or performance. Drug therapies could be paired to treat a variety of conditions. Amphetamine-like compounds could be paired to enhance neuromodulators and plasticity. SSRI's could be paired to enhance neuromodulators and plasticity. MOA inhibitors could be paired to enhance neuromodulators and plasticity. Anti-coagulants could be paired to act as clot busters during acute stroke. Various drugs could be paired to stop spasm after nerve or brain damage such as Botulinum toxin, Lidocaine, etc. Small doses of drugs of abuse could be paired to extinguish cravings in addicts.


Hormone therapy could be paired. For example, progesterone, estrogen, stress, growth, or thyroid hormone, etc. could be paired to treat traumatic brain injury or Alzheimer's disease. Glucose therapy could be paired to treat anxiety. Electrical or magnetic stimulation of the central or peripheral nervous system could be paired. For example, transcranial magnetic stimulation could be used to enhance or reduce activity in a specific brain area and thereby focus the directed cortical plasticity. Transcutaneous electrical nerve stimulation could be paired to treat chronic pain, tinnitus and other disorders. Subcutaneous electrical nerve stimulation could be paired to treat chronic pain. Stem cell therapy could be paired to treat disorders such as Parkinson's disease. Gene therapy could be paired to treat conditions such as Down's syndrome, Huntington's disease or fragile X syndrome. Hyperbaric oxygen therapy could be paired to treat carbon monoxide poisoning


Multiple therapies could be paired simultaneously or sequentially.


None of the description in the present application should be read as implying that any particular element, step, or function is an essential element which must be included in the claim scope: THE SCOPE OF PATENTED SUBJECT MATTER IS DEFINED ONLY BY THE ALLOWED CLAIMS. Moreover, none of these claims are intended to invoke paragraph six of 35 USC section 112 unless the exact words “means for” are followed by a participle.


The claims as filed are intended to be as comprehensive as possible, and NO subject matter is intentionally relinquished, dedicated, or abandoned.

Claims
  • 1. A method of treating a stroke motor deficit in a patient comprising: providing a neurostimulator to the patient to stimulate a vagus nerve of the patient electrically;detecting a preliminary event that anticipates a pairing event included in a motor therapy;initiating, based on detection of the preliminary event, stimulation of the patient's vagus nerve with the neurostimulator before a beginning of the pairing event;continuously applying the stimulation of the patient's vagus nerve with the neurostimulator so that the stimulation overlaps an initial interval in a duration of the pairing event; andthereby reducing the patient's stroke motor deficit.
  • 2. The method of claim 1, wherein the neurostimulator provides a series of electrical pulse trains.
  • 3. The method of claim 1, wherein the neurostimulator provides a programmed sequence of electrical pulse trains.
  • 4. The method of claim 1, wherein the neurostimulator provides an electrical pulse train in response to a received signal.
  • 5. The method of claim 1, wherein the motor therapy is a sequence of therapeutic motions.
  • 6. The method of claim 1, wherein the motor therapy is a therapeutic motion.
  • 7. The method of claim 1, wherein the motor therapy is a sequence of motions.
  • 8. The method of claim 1, wherein the patient's vagus nerve is also stimulated after the performance of the motor therapy.
PRIORITY CLAIM

The present application is a Continuation of U.S. application Ser. No. 14/809,781, filed Jul. 27, 2015, which claims priority to U.S. application Ser. No. 12/485,040, filed Jun. 15, 2009, which claims priority benefits under 35 U.S.C. § 119(e) from U.S. Provisional Application No. 61/077,648, filed on Jul. 2, 2008 and entitled “Treatment of Tinnitus with Vagus Nerve Stimulation”; U.S. Provisional Application No. 61/078,954, filed on Jul. 8, 2008 and entitled “Neuroplasticity Enhancement”; U.S. Provisional Application No. 61/086,116, filed on Aug. 4, 2008 and entitled “Tinnitus Treatment Methods and Apparatus”; and U.S. Provisional Application No. 61/149,387, filed on Feb. 3, 2009 and entitled “Healing the Human Brain: The Next Medical Revolution.” The present application incorporates the foregoing disclosures herein by reference.

US Referenced Citations (348)
Number Name Date Kind
2641259 Bartrow Jun 1953 A
3750653 Simon Aug 1973 A
3796221 Hagfors Mar 1974 A
3830242 Greatbatch Aug 1974 A
3885211 Gutai Apr 1975 A
3893462 Manning Jul 1975 A
3942535 Schulman Mar 1976 A
4019519 Geerling Apr 1977 A
4044775 McNichols Aug 1977 A
4154239 Turley May 1979 A
4167179 Kirsch Sep 1979 A
4361153 Slocum et al. Nov 1982 A
4399818 Money Aug 1983 A
4541432 Molina-Negro et al. Sep 1985 A
4592359 Galbraith Jun 1986 A
4612934 Borkan Sep 1986 A
4661103 Harman Apr 1987 A
4723536 Rauscher et al. Feb 1988 A
4750499 Hoffer Jun 1988 A
4832033 Maher et al. May 1989 A
4883067 Knispel et al. Nov 1989 A
4902987 Albright Feb 1990 A
4932405 Peeters et al. Jun 1990 A
4977895 Tannenbaum Dec 1990 A
5192285 Bolscher Mar 1993 A
5193539 Schulman et al. Mar 1993 A
5193540 Schulman et al. Mar 1993 A
5222494 Baker, Jr. Jun 1993 A
5234316 Rupprecht Aug 1993 A
5250026 Ehrlich et al. Oct 1993 A
5265624 Bowman Nov 1993 A
5279554 Turley Jan 1994 A
5288291 Teoh Feb 1994 A
5312439 Loeb May 1994 A
5324316 Schulman et al. Jun 1994 A
5330515 Rutecki et al. Jul 1994 A
5335657 Terry, Jr. et al. Aug 1994 A
5363858 Farwell Nov 1994 A
5405367 Schulman et al. Apr 1995 A
5474082 Junker Dec 1995 A
5559507 Beigel Sep 1996 A
5571148 Loeb et al. Nov 1996 A
5593432 Crowther et al. Jan 1997 A
5662689 Elsberry et al. Sep 1997 A
5735887 Barreras, Sr. et al. Apr 1998 A
5741316 Chen et al. Apr 1998 A
5755747 Daly et al. May 1998 A
5776170 MacDonald et al. Jul 1998 A
5779665 Mastrototaro et al. Jul 1998 A
5782874 Loos Jul 1998 A
5785680 Niezink et al. Jul 1998 A
5800458 Wingrove Sep 1998 A
5814092 King Sep 1998 A
5833603 Kovacs et al. Nov 1998 A
5833714 Loeb Nov 1998 A
5871512 Hemming et al. Feb 1999 A
5899922 Loos May 1999 A
5913882 King Jun 1999 A
5938690 Law et al. Aug 1999 A
5945938 Chia et al. Aug 1999 A
5954758 Peckham et al. Sep 1999 A
5957958 Schulman et al. Sep 1999 A
5970398 Tuttle Oct 1999 A
6009350 Renken Dec 1999 A
6051017 Loeb et al. Apr 2000 A
6104956 Naritoku et al. Aug 2000 A
6141588 Cox et al. Oct 2000 A
6164284 Schulman et al. Dec 2000 A
6175764 Loeb et al. Jan 2001 B1
6181965 Loeb et al. Jan 2001 B1
6181969 Gard Jan 2001 B1
6185452 Schulman et al. Feb 2001 B1
6185455 Loeb et al. Feb 2001 B1
6201980 Darrow et al. Mar 2001 B1
6208894 Schulman et al. Mar 2001 B1
6208902 Boveja Mar 2001 B1
6214032 Loeb et al. Apr 2001 B1
6221908 Kilgard et al. Apr 2001 B1
6240316 Richmond et al. May 2001 B1
6263247 Mueller et al. Jul 2001 B1
6270472 Antaki et al. Aug 2001 B1
6308102 Sieracki et al. Oct 2001 B1
6339725 Naritoku et al. Jan 2002 B1
6345202 Richmond et al. Feb 2002 B2
6354989 Nudeshima Mar 2002 B1
6366814 Boveja et al. Apr 2002 B1
6394947 Leyseiffer May 2002 B1
6409655 Wilson et al. Jun 2002 B1
6415184 Ishikawa et al. Jul 2002 B1
6430443 Karell Aug 2002 B1
6430444 Borza Aug 2002 B1
6447448 Ishikawa et al. Sep 2002 B1
6456866 Tyler et al. Sep 2002 B1
6458157 Suaning Oct 2002 B1
6463328 John Oct 2002 B1
6480730 Darrow et al. Nov 2002 B2
6505075 Weiner Jan 2003 B1
6516808 Schulman Feb 2003 B2
6546290 Shloznikov Apr 2003 B1
6567689 Burbank et al. May 2003 B2
6572543 Christopherson et al. Jun 2003 B1
6582441 He et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6591139 Loftin et al. Jul 2003 B2
6592518 Denker et al. Jul 2003 B2
6622038 Barrett et al. Sep 2003 B2
6626676 Freer Sep 2003 B2
6650943 Whitehurst et al. Nov 2003 B1
6658297 Loeb Dec 2003 B2
6658301 Loeb et al. Dec 2003 B2
6676675 Mallapragada et al. Jan 2004 B2
6690974 Archer et al. Feb 2004 B2
6695885 Schulman et al. Feb 2004 B2
6712753 Manne Mar 2004 B2
6721603 Zabara et al. Apr 2004 B2
6731979 MacDonald May 2004 B2
6733485 Whitehurst et al. May 2004 B1
6735474 Loeb et al. May 2004 B1
6735475 Whitehurst et al. May 2004 B1
6760626 Boveja Jul 2004 B1
6788975 Whitehurst et al. Sep 2004 B1
6796935 Savino Sep 2004 B1
6804561 Stover Oct 2004 B2
6829508 Schulman et al. Dec 2004 B2
6832114 Whitehurst et al. Dec 2004 B1
6836685 Fitz Dec 2004 B1
6844023 Schulman et al. Jan 2005 B2
6845267 Harrison et al. Jan 2005 B2
6855115 Fonseca et al. Feb 2005 B2
6871099 Whitehurst et al. Mar 2005 B1
6885888 Rezai Apr 2005 B2
6895279 Loeb et al. May 2005 B2
6895280 Meadows et al. May 2005 B2
6941171 Mann et al. Sep 2005 B2
6971984 Ardizzone Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6990377 Gliner et al. Jan 2006 B2
7003352 Whitehurst Feb 2006 B1
7006870 Whitehurst et al. Feb 2006 B1
7013177 Whitehurst et al. Mar 2006 B1
7024247 Gliner et al. Apr 2006 B2
7027860 Bruninga et al. Apr 2006 B2
7054689 Whitehurst et al. May 2006 B1
7054691 Kuzma et al. May 2006 B1
7062330 Boveja et al. Jun 2006 B1
7076307 Boveja et al. Jul 2006 B2
7103408 Haller et al. Sep 2006 B2
7107103 Schulman et al. Sep 2006 B2
7114502 Schulman et al. Oct 2006 B2
7117034 Kronberg Oct 2006 B2
7132173 Daulton Nov 2006 B2
7006875 Kuzma et al. Dec 2006 B1
7146217 Firlik et al. Dec 2006 B2
7147604 Allen et al. Dec 2006 B1
7149574 Yun et al. Dec 2006 B2
7155279 Whitehurst et al. Dec 2006 B2
7174215 Bradley Feb 2007 B2
7184837 Goetz Feb 2007 B2
7187968 Wolf et al. Mar 2007 B2
7191012 Boyeja et al. Mar 2007 B2
7194007 Beadle et al. Mar 2007 B1
7209787 DiLorenzo Apr 2007 B2
7209788 Nicolelis et al. Apr 2007 B2
7209792 Martin et al. May 2007 B1
7211048 Najafi et al. May 2007 B1
7212866 Griffith May 2007 B1
7221981 Gliner May 2007 B2
7231256 Wahlstrand et al. Jun 2007 B2
7236822 Dobak, III Jun 2007 B2
7236830 Gliner Jun 2007 B2
7236831 Firlik et al. Jun 2007 B2
7256695 Hamel et al. Aug 2007 B2
7290890 Yoshida et al. Nov 2007 B2
7292890 Whitehurst et al. Nov 2007 B2
7299096 Balzer et al. Nov 2007 B2
7302298 Lowry et al. Nov 2007 B2
7305268 Gliner et al. Dec 2007 B2
7324852 Barolat et al. Jan 2008 B2
7328069 Gerber Feb 2008 B2
7330756 Marnfeldt Feb 2008 B2
7337004 Classen et al. Feb 2008 B2
7353064 Gliner et al. Apr 2008 B2
7359751 Erickson et al. Apr 2008 B1
7361135 Drobnik et al. Apr 2008 B2
7369897 Boveja et al. May 2008 B2
7373204 Gelfand et al. May 2008 B2
7384403 Sherman Jun 2008 B2
7386348 North et al. Jun 2008 B2
7389145 Kilgore et al. Jun 2008 B2
7406105 DelMain et al. Jul 2008 B2
7437195 Policker et al. Oct 2008 B2
7437196 Wyler et al. Oct 2008 B2
7463927 Chaouat Dec 2008 B1
7481771 Fonseca et al. Jan 2009 B2
7483747 Gliner et al. Jan 2009 B2
7489561 Armstrong et al. Feb 2009 B2
7489966 Leinders et al. Feb 2009 B2
7493172 Whitehurst et al. Feb 2009 B2
7526341 Goetz et al. Apr 2009 B2
7529582 DiLorenzo May 2009 B1
7542804 Mandell Jun 2009 B2
7547353 Reyes et al. Jun 2009 B2
7555344 Maschino et al. Jun 2009 B2
7555345 Wahlstrand et al. Jun 2009 B2
7555347 Loeb Jun 2009 B2
7558631 Cowan et al. Jul 2009 B2
7563279 Lasater Jul 2009 B2
7565199 Sheffield et al. Jul 2009 B2
7565200 Wyler et al. Jul 2009 B2
7577481 Firlik et al. Aug 2009 B2
7590454 Garabedian et al. Sep 2009 B2
7593776 Loeb et al. Sep 2009 B2
7596413 Libbus et al. Sep 2009 B2
7603174 DeRidder Oct 2009 B2
7603178 North et al. Oct 2009 B2
7613519 DeRidder Nov 2009 B2
7613520 DeRidder Nov 2009 B2
7616990 Chavan et al. Nov 2009 B2
7630771 Cauller Dec 2009 B2
7634317 Ben-David et al. Dec 2009 B2
7636603 Overstreet et al. Dec 2009 B1
7715915 Ryu et al. May 2010 B1
7765013 Blick et al. Jul 2010 B2
7769466 Denker et al. Aug 2010 B2
7786867 Hamel et al. Aug 2010 B2
7801615 Meadows et al. Sep 2010 B2
7822480 Park et al. Oct 2010 B2
20010016683 Darrow et al. Aug 2001 A1
20020022872 Gielen et al. Feb 2002 A1
20020029005 Levendowski et al. Mar 2002 A1
20020051806 Mallapragada et al. May 2002 A1
20020058853 Kaplan May 2002 A1
20020077672 Govari et al. Jun 2002 A1
20020193845 Greenberg et al. Dec 2002 A1
20030004411 Govari et al. Jan 2003 A1
20030013948 Russell Jan 2003 A1
20030014091 Rastegar et al. Jan 2003 A1
20030114899 Woods et al. Jun 2003 A1
20030139677 Fonseca et al. Jul 2003 A1
20030139783 Kilgore et al. Jul 2003 A1
20030144709 Zabara et al. Jul 2003 A1
20030171758 Gibson et al. Sep 2003 A1
20030225331 Diederich et al. Dec 2003 A1
20040172075 Shafer et al. Sep 2004 A1
20040172083 Penner Sep 2004 A1
20040176831 Gliner et al. Sep 2004 A1
20040181261 Manne Sep 2004 A1
20040031065 Barth Dec 2004 A1
20040253209 Soykan et al. Dec 2004 A1
20040267152 Pineda Dec 2004 A1
20050015014 Fonseca et al. Jan 2005 A1
20050021100 Tsukamoto et al. Jan 2005 A1
20050070974 Knudson et al. Mar 2005 A1
20050131386 Freeman et al. Jun 2005 A1
20050137652 Cauller et al. Jun 2005 A1
20050143789 Whitehurst et al. Jun 2005 A1
20050209667 Erickson et al. Sep 2005 A1
20050222641 Pless Oct 2005 A1
20050245989 Davis Nov 2005 A1
20050251222 Barrett Nov 2005 A1
20050256551 Schulman et al. Nov 2005 A1
20050258242 Zarembo Nov 2005 A1
20060058570 Rapach et al. Mar 2006 A1
20060173263 He et al. Aug 2006 A1
20060173493 Armstrong et al. Aug 2006 A1
20060195154 Jaax et al. Aug 2006 A1
20060206149 Yun Sep 2006 A1
20060224214 Koller et al. Oct 2006 A1
20060241354 Allen Oct 2006 A1
20060247719 Maschino et al. Nov 2006 A1
20060271110 Vernon et al. Nov 2006 A1
20070010809 Hovda et al. Jan 2007 A1
20070021786 Parnis et al. Jan 2007 A1
20070027486 Armstrong Feb 2007 A1
20070027504 Barrett et al. Feb 2007 A1
20070032734 Najafi et al. Feb 2007 A1
20070077265 Klueh et al. Apr 2007 A1
20070123938 Haller et al. May 2007 A1
20070179534 Firlik et al. Aug 2007 A1
20070191908 Jacob et al. Aug 2007 A1
20070225767 Daly et al. Sep 2007 A1
20070265172 Patel et al. Nov 2007 A1
20070265683 Ehrlich Nov 2007 A1
20070275035 Herman et al. Nov 2007 A1
20070293908 Cowan et al. Dec 2007 A1
20080033351 Trogden et al. Feb 2008 A1
20080033502 Harris et al. Feb 2008 A1
20080058874 Westlund Mar 2008 A1
20080058892 Haefner et al. Mar 2008 A1
20080065182 Strother et al. Mar 2008 A1
20080084898 Miyaho et al. Apr 2008 A1
20080084911 Yerlikaya Apr 2008 A1
20080084941 Mohanty et al. Apr 2008 A1
20080084951 Chen et al. Apr 2008 A1
20080084972 Burke et al. Apr 2008 A1
20080084986 Kumarasamy et al. Apr 2008 A1
20080103548 Fowler et al. May 2008 A1
20080109046 Lima et al. May 2008 A1
20080243204 Uthman et al. Oct 2008 A1
20080259681 Branch et al. Oct 2008 A1
20080275369 Fndriks Nov 2008 A1
20080281210 Nunez et al. Nov 2008 A1
20080281212 Nunez et al. Nov 2008 A1
20080281368 Bulkes et al. Nov 2008 A1
20080319506 Cauller Dec 2008 A1
20090015331 Segarra Jan 2009 A1
20090024042 Nunez et al. Jan 2009 A1
20090024189 Lee et al. Jan 2009 A1
20090030476 Hargrove Jan 2009 A1
20090049321 Balatsos et al. Feb 2009 A1
20090132003 Borgens et al. May 2009 A1
20090149918 Krulevitch et al. Jun 2009 A1
20090157142 Cauller Jun 2009 A1
20090157145 Cauller Jun 2009 A1
20090157147 Cauller et al. Jun 2009 A1
20090157150 Cauller Jun 2009 A1
20090157151 Cauller et al. Jun 2009 A1
20090163889 Cauller et al. Jun 2009 A1
20090198293 Cauller et al. Aug 2009 A1
20090209804 Seiler et al. Aug 2009 A1
20090216115 Seiler et al. Aug 2009 A1
20090221928 Einav Sep 2009 A1
20090247939 Rue et al. Oct 2009 A1
20090264813 Chang Oct 2009 A1
20090292325 Cederna et al. Nov 2009 A1
20090312594 Lamoureux et al. Dec 2009 A1
20100004705 Kilgard et al. Jan 2010 A1
20100004717 Kilgard et al. Jan 2010 A1
20100016766 Zhang Jan 2010 A1
20100022908 Cauller Jan 2010 A1
20100036211 La Rue et al. Feb 2010 A1
20100036445 Sakai et al. Feb 2010 A1
20100057160 De Ridder Mar 2010 A1
20100063564 Libbus et al. Mar 2010 A1
20100069992 Aghassian et al. Mar 2010 A1
20100069994 Cauller Mar 2010 A1
20100100010 Andarawis et al. Apr 2010 A1
20100100079 Berkcan et al. Apr 2010 A1
20100105991 Te Vrugt Apr 2010 A1
20100106217 Colborn Apr 2010 A1
20100125314 Bradley et al. May 2010 A1
20100137961 Moffitt et al. Jun 2010 A1
20100145216 He et al. Jun 2010 A1
20100145401 Pastore et al. Jun 2010 A1
20100174341 Bolea et al. Jul 2010 A1
20100222844 Troosters et al. Sep 2010 A1
20100331921 Bornzin et al. Dec 2010 A1
20110004266 Sharma Jan 2011 A1
Foreign Referenced Citations (49)
Number Date Country
101648053 Feb 2010 CN
3405630 Jun 1985 DE
2004050616 Mar 2006 DE
112008001669 May 2010 DE
11208003192 Oct 2010 DE
11208003194 Feb 2011 DE
11208003180 Mar 2011 DE
0247649 Feb 1987 EP
1575665 Sep 2005 EP
1719540 Aug 2006 EP
1785160 May 2007 EP
9619257 Jun 1996 WO
9843701 Jun 1996 WO
9817628 Apr 1998 WO
02082982 Oct 2002 WO
03003791 Jan 2003 WO
03015863 Feb 2003 WO
03018113 Mar 2003 WO
03076010 Sep 2003 WO
2004060144 Jul 2004 WO
2005061045 Jul 2005 WO
2005067792 Jul 2005 WO
2006020377 Feb 2006 WO
2006029007 Mar 2006 WO
2006029257 Mar 2006 WO
2006091611 Aug 2006 WO
2007073557 Jun 2007 WO
2007098202 Aug 2007 WO
2007106692 Sep 2007 WO
2007136657 Nov 2007 WO
2007146213 Dec 2007 WO
2008103977 Aug 2008 WO
2008133797 Nov 2008 WO
2008150348 Dec 2008 WO
2008151059 Dec 2008 WO
2009018172 Feb 2009 WO
2009035515 Mar 2009 WO
2009070697 Jun 2009 WO
2009070705 Jun 2009 WO
2009070709 Jun 2009 WO
2009070715 Jun 2009 WO
2009070719 Jun 2009 WO
2009070738 Jun 2009 WO
2009110935 Sep 2009 WO
2009111012 Sep 2009 WO
2009015104 Dec 2009 WO
2010002936 Jan 2010 WO
2010022071 Feb 2010 WO
2010124321 Nov 2010 WO
Non-Patent Literature Citations (151)
Entry
Arthur, D.W. et al., “Improvements in Critical Dosimetric Endpoints Using the Contura Multilumen Ballon Breast Brachytherapy Catheter to Deliver Accelerated Partial Breast Irradiation: Preliminary Dosimetric Findings of a Phase IV Trial,” Int. J. Radiation Oncology Biol. Phys., vol. 79, No. 1, 2011, pp. 26-33.
Atluri, S. et al., “Design of a Wideband Power-Efficient Inductive Wireless Link for Implantable Biomedical Devices Using Multiple Carriers,” Proceedings of the International IEEE EMBS Conference on Neural Engineering Arlington, Virginia, Mar. 16-19, 2005, http://www.ece.ncsu.edu/erl/html2/papers/ghovanloo/2005/ghovanloo_2005_atluri.pdf.
Asgarian, F. et al., “Wireless Telemetry for Implantable Biomedical Microsystems,” Integrated Circuits and Systems (ICAS) Lab., Department of Electrical and Computer Eng., K.N. Toosi University of Technology, www.intechopen.com/download/pdf/pdfs_id/12899.
Avitall, B. et al., “Physics and Engineering of Transcatheter Cardiac Tissue Ablation,” Journal of the American College of Cardiology, vol. 22, No. 3, Sep. 1993, pp. 921-932.
Cavalcanti, A. et al., “Nanorobot for Treatment of Patients with Artery Occlusion,” Proceedings of Virtual Concept, 2006, 10 pages.
Chaimanonart, N. et al., “Adaptive RF Power for Wireless Implantable Bio-Sensing Network to Monitor Untethered Laboratory Animal Real-Time Biological Signals,” IEEE Sensors, Oct. 2008, pp. 1241-1244, Abstract.
Chandrakasan, AP et al., “Ultra-Power Electronics for Biomedical Applications”, Annual Rev. Biomed. Eng., 2008, Abstract.
Cheung, K.C., “Implantable Microscale Neural Interfaces,” Biomed Microdevices, Dec. 2007, pp. 923-938, Abstract.
Citro, R. et al., “Intracardiac Echocardiography to Guide Transseptal Catheterization for Radiofrequency Catheter Ablation of Left-Sided Accessory Pathways: two case reports,” Cardiovascular Ultrasound, 2004, 7 pages.
Dimyan, M.A. et al, “Neuroplasticity in the Context of Motor Rehabilitation After Stroke,” Nat. Rev. Neurol. Feb. 2011, Review. http://www.nature.com/nrneurol/journal/v7/n2/abs/nrneurol.2010.200.html?http://www.ncbi.nlm.nih.gov/pubmed/21243015.
Fotopoulou, K. et al., “Wireless Powering of Implanted Sensors Using RF Inductive Coupling,” 5th IEEE Conference on Sensors, Oct. 2006, pp. 765-768, Abstract.
Shepherd, RD et al., “Electrical Stimulation of the Auditory Nerve: II. Effect of Stimulus Waveshape on Single Fibre Response Properties,” Hear Res., vol. 130, Apr. 1999, pp. 171-188, Abstract.
Sit, Ji-Jon et al., “A Low-Power Blocking-Capacitor-Free Charge-Balanced Electrode-Stimulator Chip with Less Than 6 nA DC Error for 1-mA Full-Scale Stimulation,” IEEE Transactions on Biomedical Circuits and Systems, vol. 1, No. 3, Sep. 2007, pp. 172-183.
Sooksood, K., et al., “Recent Advances in Charge Balancing for Functional Electrical Stimulation”, Conf. Proc. IEEE Eng. Med. Biol. Soc., Nov. 13, 2009, Abstract.
Sooksood, K., et al., “An Experimental Study on Passive Charge Balancing,” Adv. Radio Sci., vol. 7, 2009, pp. 197-200.
Suaning, G.J. et al., “CMOS Neurostimulation ASIC with 100 Channels, Scaleable Output, and Bidirectional Radio-Frequency,” Biomedical Engineering, IEEE Transactions on Biomedical Engineering, vol. 48, Issue 2, pp. 248-260, Abstact, Feb. 2001.
Van Greevenbroek, B., “The Development of Neuro-Prosthetic Devices,” Feb. 10, 2011, http://www.google.com/url?sa=t&source=web&cd=17&ved=0CH4QFjAQ&url=http%3A%2F%2Figitur-archive.library.uu.nl%2Fstudent-theses%2F2011-0210-200413%2520development%2520of%252Neuro-Prosthetic%2520Devices%2520(Pdf%2520af).pdf%ei=rUeuTeTMN6W60QGt1bWq.
Van Wieringen A. et al., “Effects of waveform Shape on Human Sensitivity to Electrical Stimulation of the Inner Ear,” Hear Res., Feb. 2005, Abstract.
Venkataraman, S. et al., “RF-Front End for Wireless Powered Neural Applications,” 51st Midwest Symposium Circuits and Systems, Aug. 2008, pp. 682-685, Abstract.
Wise, K.D. et al., “Wireless implantable Microsystems: High-Density Electronic Interfaces to the Nervous System,” Proceedings of the IEEE, vol. 92, Issue 1, Jan. 2004, pp. 76-97, Abstract.
Xing et al., “Research Progress of Subrentinal Implant Based on Electronic Stimulation,” Engineering in Medicine and Biology Society, 2005, pp. 1289-1292, Abstract http://ieeexplore.iee.org/search/srchabstract.jsp?queryText=%28Implant%20And%20induction%29%20AND %20%28antenna%20OR%20coil%29%20AND%20%28transfer%20OR%20relay%29%20AND%20%28multiple%20OR%20plural%20OR%20array%29%20AND%20%28medic*%20OR%20surg*%20OR%2.
Yazdandoost, KY et al., “An Antenna for Medical Implant Communications System,” European Microwave Conference, 2007, pp. 968-971, Abstract.
Bohotin, C., Scholsem, M., Bohotin, V., Franzen, R. and Schoenen, J., “Vagus Nerve Stimulation Attenuates Hear- and Formalin-Induced Pain in Rats”, Neuroscience Letters, 2003, vol. 351, pp. 79-82.
Bohotin, C., Scholsem, M., Multon, S., Martin, D., Bohotin, V., Schoenen, J., Vagus Nerve Stimulation in Awake Rats Reduces Formalin-Induced Nociceptive Behavior and Fos-Immunoreactivity in Trigeminal Nucleus Caudalis, Pain 101, 2003, pp. 3-12.
Burridge, J. and Etherington, R., “A Preliminary Clinical Study using RF BION Microstimulators to Facilitate Upper Limb Function in Hemiplegia”, Advances in Clinical Neurosciences and Rehabilitation, May/Jun. 2004, vol. 4, pp. 26-27.
Cauller, L. and Lee, J., “In Vivo Tests of Switched-Capacitor Neural Stimulation for Use in Minimally-Invasive Wireless Implants”, IEEE International Symposium on Circuits and Systems, 2008, 2 pages.
Chuang, H., “Numerical Computation of Fat Layer Effects on Microwave Near-Field Radiation to the Abdomen of a Full-Scale Human Body Model”, IEEE Transactions on Microwave Theory and Techniques, vol. 45, Jan. 1997, pp. 118-125.
Cogan, S., “Neural Stimulation and Recording Electrodes” Annual Review of Biomedical Engineering, vol. 1, 2008, pp. 275-309.
Ghovanloo, M., “A Switched-Capacitor Based Neurostimulating System for Low-Power Wireless Microstimulating Systems”, IEEE International Symposium on Circuits and Systems, May 2006, pp. 2197-2200.
Gopalkrishnan, P. and Sluka, K., “Effect of Varying Frequency, Intensity, and Pulse Duration of Transcutaneous Electrical Nerve Stimulation on Primary Hyperalgesia in Inflamed Rats”, The American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation, vol. 81, Jul. 2000, pp. 984-990.
Goroszeniuk, T., Kothari, S. and Hamann, W., “Subcutaneous Neuromodulating Implant Targeted at the Site of Pain”, Regional Anesthesia and Pain Medicine, vol. 31, No. 2, Mar./Apr. 2006, pp. 168-171.
Huang et al., “A 0.5-mW Passive Telemetry IC for Biomedical Applications”, IEEE Journal of Solid-State Circuits, vol. 33, No. 7, Jul. 1998, pp. 937-946.
Kilgore, K., Bhadra, N. and Snyder, J., “Treatment of Neuroma Pain Using High Frequency Alternating Current” poster, 1 page.
Kipke, D., Vetter, R., Williams, J., and Hetke, J., “Silicon-Substrate Intracortical Microelectrode Arrays for Long-Term Recording of Neuronal Spike Activity in Cerebral Cortex”, IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 11, No. 2, Jun. 2003, pp. 151-155.
Li, C., and Bak, A., “Excitability Characteristics of the A- and C-Fibers in a Peripheral Nerve”, Experimental Neurology, vol. 50, 1976, pp. 67-79.
Mendlin, A., Martin F.J., A. and Jacobs, B., “Dopaminergic Input is Required for Increases in Serotonin Output Produced by Behavioral Activation: An In Vivo Microdialysis Study in Rat Forebrain”, Neuroscience, vol. 93, No. 3, 1999, pp. 897-905.
Millard, R. and Shepherd, R., “A Fully Implantable Stimulator for use in Small Laboratory Animals”, Journal of Neuroscience Methods, 2007, pp. 168-177.
Mokwa et al., “Micro-Transponder Systems for Medical Applications”, IEEE Transactions on Instrumentation and Measurement, vol. 50, No. 6, Dec. 2001, pp. 1551-1555.
Nair, S.G. and Gudelsky, G.A., “Effect of a Serotonin Depleting Regimen of 3, 4-Methylenedioxymethamphetamine (MDMA) on the Subsequent Stimulation of Acetylcholine Release in the Rat Prefrontal Cortex”, Elsevier Brain Research Bulletin 69, Jan. 23, 2006, pp. 382-387.
Parikh, V., Pomerleau, F., Huettl, P, Gerhardt, G., Sarter, M. and Bruno, J.P., “Rapid Assessment of in Vivo Cholinergic Transmission by Amperometric Detection of Changes in Extracellular Choline Levels”, European Journal of Neuroscience, vol. 20, Jul. 12, 2004, pp. 1545-1554.
Rainov, N., Fels, C., Heidecke, V. and Burkert, W., “Epidural Electrical Stimulation of the Motor Cortex in Patients with Facial Neuralgia”, Clinical Neurology and Neurosurgery 99, 1997, pp. 205-209.
Saito, Y., Matida. S., Anami, S. Baba, H., Kinbara, A., Horikoshi, G., and Tanaka, J., “Breakdown of Alumina RF Windows”, American Institute of Physics, Rev. Sci. Instrum., vol. 60, No. 7, Jul. 1989, pp. 1736-1740.
Sakai, Y., Nishijima, Y., Mikuni, N. and Iwata, N., “An Experimental Model of Hyper-Irritability in the Trigeminal Skin Field of the Rat”, Pain, vol. 7, 1979, pp. 147-157.
Sandkuhler, J., Chen, J., Cheng, G. and Randic, M., “Low-Frequency Stimulation of Afferent Aδ-Fibers Induces Long-Term Depression at Primary Afferent Synapses with Substantia Gelatinosa Neurons in the Rat”, The Journal of Neuroscience, vol. 17, Issue 16, Aug. 15, 1997, pp. 6473-6491.
Sandkuhler, J., “Understanding LTP in Pain Pathways”, Molecular Pain, vol. 3, Issue 9, Apr. 3, 2007, pp. 1-9.
Sheng, L., Nishiyama, K., Honda, T., Sugiura, M., Yaginuma, H. and Sugiura, Y., “Suppressive Affects of Neiting Acupuncture on Toothache: An Experimental Analysis on Fos Expression Evoked by Tooth Pulp Stimulation in the Trigeminal Subnucleus Pars Caudalis and the Periaqueductal Gray of Rats”, Neuroscience Research, vol. 38, 2000, pp. 331-339.
Simpson, J. and Ghovanloo, M., “An Experimental Study of Voltage, Current, and Charge Controlled Stimulation Front-End Circuitry”, IEEE International Symposium on Circuits and Systems, May 2007, pp. 325-328.
Simpson, J., Krishnamurthy, G., Feller, G., Murrow, R., and Ghovanloo, M., “A Switched-Capacitor Based Neurostimulating System for Low-Power Head-Mounted Deep Brain Stimulators”, NCBIONICS, North Carolina State University, 1 page.
Spinner, R., “Outcomes for Peripheral Entrapment Syndromes”, Clinical Neurosurgery, vol. 53, 2006, pp. 285-294.
Tsodyks, M., “Computational neuroscience grand challenges—a humble attempt at future forecast”, Frontiers in Neuroscience, vol. 2, Jul. 2008, pp. 17-18.
Vetter, R., et al., Chronic Neural Recording Using Silicon-Substrate Microelectrode Arrays Implanted in Cerebral Cortex, IEEE Transactions on Biomedical Engineering, vol. 51, No. 6, Jun. 2004, pp. 896-904.
Vuckovic, A. and Rijkhoff, N., “Different Pulse Shapes for Selective Large Fibre Block in Sacral Nerve Roots Using a Technique of Anodal Block: An experimental Study” Medical & Biological Engineering & Computing, vol. 42, 2004, pp. 817-824.
Wever, R. and Hemrika, W., “Vanadium Haloperoxidases”, Handbook of Metalloproteins, John Wiley & Sons, Ltd. Chichester, 2001, pp. 1416-1428.
EZstim II Peripheral Nerve Locator and Stimulator, Model ES400, Operator's Manual, Life-Tech, Inc., 2005, 29 pages.
“Multi-Program Neurostimulator”, Implant Manual, Medtronic, 2006, 16 pages.
“Stimuplex Nerve Stimulator” brochure, Braun, 4 pages.
Office Action dated Aug. 19, 2010, 8 pages, U.S. Appl. No. 12/323,854, filed Nov. 26, 2008.
Office Action dated Feb. 24, 2011, 7 pages, U.S. Appl. No. 12/323,854, filed Nov. 26, 2008.
Office Action dated Dec. 22, 2010, 11 pages, U.S. Appl. No. 12/323,904, filed Nov. 26, 2008.
Office Action dated Dec. 2, 2010, 9 pages, U.S. Appl. No. 12/323,934, filed Nov. 26, 2008.
George, M.S. et al., “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy,” Biol Psychiatry, 2000, pp. 287-295. http://www.ncbi.nlm.nih.gov/pubmed/10686263.
Gimsa, J. et al., “Choosing Electrodes for Deep Brain Stimulation Experiments—Electrochemical Considerations,” J Neurosci. Methods, Mar. 30, 2005, Abstract.
Hijazi, N. et al., “Wireless Power and Data Transmission System for a Micro Implantable Intraocular Vision Aid,” Biomed Tech (Berl), 2002; 47 Suppl 1 Pt1:174-5, Abstract.
Kim, S. et al., “Influence of System Integration and Packaging for a Wireless Neural Interface on its Wireless Powering Performance,” 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 2008, pp. 3182-3185, Abstract.
Laskovski, A. et al., “Wireless Power Technology for Biomedical Implants,” University of Newcastle, Australia, www.intechopen.com/download/pdf/pdfs_id/8797, Oct. 2009.
Loeb, G.E. et al., “RF-Powered BIONs for Stimulation and Sensing,” 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2004, vol. 2, p. 4182, Abstract.
Lu, HM et al., “MEMS-Based Inductively Coupled RFID Transponder for Implantable Wireless Sensor Applications,” IEEE Transactions on Magnetics, vol. 43, No. 6, Jun. 2007, pp. 2412-2414.
Mokwa et al., “Intraocular Epiretinal Prosthesis to Restore Vision in Blind Humans,” 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 2008, p. 5790, Abstract.
Mouine, J. et al., “A Completely Programmable and Very Flexible Implantable Pain Controller,” Proc. of the 22nd Annual Intern Conference of the IEEE, vol. 2, 2000, pp. 1104-1107, Abstract.
Mounaim, F. et al., “Miniature Implantable System Dedicated to Bi-Channel Selective Neurostimulation,” IEEE International Symposium on Circuits and Systems, 2007, pp. 2072-2075, Abstract.
Myers, F.B. et al., “A Wideband Wireless Neural Stimulation Platform for High-Density Microelectrode Arrays,” 28th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 30, 2006, pp. 4404-4407, Abstract.
Papazoglou, C. et al., “Endoluminal Grafting: The Arizona Heart Institute Experience,” International Congress VIII on Endovascular Interventions, Breaking Barriers, Scottsdale, Arizona, Feb. 12-16, 1995, pp. 89-129.
Peters, T.K. et al., “The Evolution Strategy—A Search Strategy Used in Individual Optimization of Electrica Therapeutic Carotid Sinus Nerve Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 36, Issue 7, pp. 668-675, Abstract http://ieeexplore.ieee.org/search/srchabstract.jsp?tp=&arnumber=32098&queryText%3D%28Implant+And+induction%29+AND+%28antenna+OR+coil%29+AND+%28t%29%26searchWit, Abstract, 1989.
Popovic, D.B. et al., “Electrical Stimulation as a Means for Achieving Recovery of Function in Stoke Patients,” NeuroRehabilitation, vol. 1, 2009, pp. 45-58. Abstract http://www.ncbi.nlm.nih.gov/pubmed/19713618.
Sawan, M., “Medical Microsystems for the Recovery of Vital Neural Functions,” ncku.edu.tw polystim neurotechnologies Tianan, Taiwan, http://www.google.com/url?sa=t&source=web&cd=1&ved=0CBcQFjAA&url=http%3A%2F%2Ford.ncku.edu.tw%2Fezfiles%2F3%2F1003%2Fimg%2F467%2F20080911_ppt.pdei=elayTZeNO-Ls0gHW7IHCCw&usg=AFQjCNE8HVhol0Y63ztvd1sxK8-8aDdLAw&sig2=c7qWn1zQ2QUrwRMDvC53Gw.
Sawan, M., “Wireless Smart Implants Dedicated to Multichannel Monitoring and Microstimulation,” IEEE/ACS International Conference on Pervasive Services, Jul. 2004, pp. 21-26, Abstract.
Schwiebert, L. et al., “Research Challenges in Wireless Networks of Biomedical Sensors,” Disclosing for maximizing signal distance/minimizing power with multiple implant arrays in section 5.1, pp. 159-161, 2001.
Shabou, S. et al., “The RF Circuit Design for Magnetic Power Transmission Dedicated to Cochlear Prosthesis,” 12th IEEE International Conference on Electronics, Circuits and Systems, 2005, pp. 1-4, Abstract.
Sharma, N. et al., “Electrical Stimulation and Testosterone Differentially Enhance Expression of Regeneration-Associated Genes,” Exp Neurol., vol. 1, May 2010, pp. 183-191, Abstract.
Yekeh, K. et al., “Wireless Communications for Body Implanted Medical Device,” Asia-Pacific Microwave Conference, 2007, pp. 1-4, Abstract.
Yoon, “A dual spiral antenna for Ultra-wideband capsule endoscope system,” Department of Electronics and Electronic Engineering, Yonsei University Seoul, http://sciencestage.com/d/5302029/a-dual -spiral-antenna-for-ultra-widegand-capsule-endoscope-system.html, Abstract, Mar. 2008.
Zhang, Yi et al., “Episodic phrenic-Inhibitory Vagus Nerve Stimulation Paradoxically Induces Phrenic Long-Term Facilitation in Rats,” J Physiol., Sep. 15, 2003, pp. 981-991. Linghttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2343284.
Office Action dated Sep. 27, 2011, 7 pages, U.S. Appl. No. 12/323,854, filed Nov. 26, 2008.
Office Action dated Aug. 29, 2011, 70 pages, U.S. Appl. No. 12/323,904, filed Nov. 26, 2008.
Office Action dated Jul. 15, 2011, 36 pages, U.S. Appl. No. 12/323,934, filed Nov. 28, 2008.
Office Action dated Sep. 26, 2011, 17 pages, U.S. Appl. No. 12/324,000, filed Nov. 26, 2008.
Office Action dated Aug. 1, 2011, 9 pages, U.S. Appl. No. 12/324,044, filed Nov. 26, 2008.
Office Action dated Jan. 3, 2012, 9 pages, U.S. Appl. No. 12/485,860, filed Jun. 16, 2009.
Office Action dated Oct. 26, 2011, 11 pages, U.S. Appl. No. 12/485,857, filed Jun. 15, 2009.
Office Action dated Oct. 28, 2011, 17 pages, U.S. Appl. No. 12/558,734, filed Sep. 14, 2009.
Office Action dated Aug. 23, 2011, 4 pages, U.S. Appl. No. 12/624,383, filed Nov. 23, 2009.
Foreign Communication From a Related Counterpart Application—International Search Report, PCT/US2010/058737 dated Aug. 31, 2011, 7 pages.
Foreign Communication From a Related Counterpart Application—Written Opinion PCT/US2010/058737 dated Aug. 31, 2011, 8 pages.
Foreign Communication from a Related Counterpart Application—Office Action dated Jun. 15, 2011, German Application No. 112008003183.5.
Clark, et al., “Enhanced Recognition Memory Following Vagus Nerve Stimulation in Human Subjects,” Nature Neuroscience, vol. 2, No. 1, Jan. 1999, pp. 94-98.
Office Action dated Jul. 9, 2010, 18 pages, U.S. Appl. No. 12/323,952, filed Nov. 26, 2008.
Office Action dated Apr. 19, 2011, 8 pages, U.S. Appl. No. 12/323,952, filed Nov. 26, 2008.
Office Action dated Jan. 19, 2011, 11 pages, U.S. Appl. No. 12/323,969, filed Nov. 26, 2008.
Office Action dated Aug. 30, 2010, 5 pages, U.S. Appl. No. 12/323,969, filed Nov. 26, 2008.
Office Action dated Dec. 9, 2010, 7 pages, U.S. Appl. No. 12/324,000, filed Nov. 26, 2008.
Office Action dated Apr. 28, 2011, 8 pages, U.S. Appl. No. 12/324,000, filed Nov. 26, 2008.
Office Action dated May 5, 2011, 8 pages, U.S. Appl. No. 12/485,860, filed Jun. 16, 2009.
Office Action dated Mar. 10, 2011, 10 pages, U.S. Appl. No. 12/485,857, filed Jun. 15, 2009.
Foreign Communication From a Related Counterpart Application—International Search Report, PCT/US2008/068165, dated Dec. 24, 2008, 3 pages.
Foreign Communication From a Related Counterpart Application—International Search Report, PCT/US2008/084898, dated May 26, 2009, 6 pages.
Foreign Communication From a Related Counterpart Application—Written Opinion PCT/US2008/084898 dated May 26, 2009, 5 pages.
Foreign Communication From a Related Counterpart Application—International Search Report, PCT/US2009/049321, dated Feb. 9, 2010, 8 pages.
Foreign Communication From a Related Counterpart Application—Written Opinion, PCT/US2009/049321, dated Feb. 9, 2010, 4 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008329642, 2 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008329648, 2 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008329652, 2 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008329671, 2 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008329716, 2 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008329724, 2 pages.
Foreign Communication From a Related Counterpart Application—Office Action dated Jul. 6, 2010, Australian Application No. 2008352005, 2 pages.
Cauller, Lawrence J.; U.S. Appl. No. 12/611,105; Title: “Short-Pulse Neural Stimulation Systems, Devices and Methods”; filed Nov. 18, 2009; Specification 10 pgs.; 3 Drawing Sheets (Figs. 1-7).
Cauller, Lawrence J.; U.S. Appl. No. 12/611,110; Title: “Parasthesia Using Short-Pulse Neural Stimulation Systems, Devices and Methods”; filed Nov. 2, 2009; Specification 10 pages; 3 Drawing Sheets (Figs. 1-7).
Office Action dated Oct. 4, 2010, 11 pages, U.S. Appl. No. 12/323,952, filed Nov. 26, 2008.
Engineer, et al., “Reversing Pathological Neural Activity Using Targeted Plasticity,” Nature, vol. 47, Feb. 3, 2011, pp. 101-106.
“Neurology: a Queen Square textbook,” edited by Charles Clarke et al., Wiley-Blackwell, edited by Charles Clarke et al., 2008, ISBN 978-1-4051-3443-9, pp. v and 109-187.
“Clinical Overview and Phenomenology of Movement Disorders,” Chapter 1 of Principles and Practice of Movement Disorders (Second Edition), Fahn, Stanle, et al. Saunders, an imprint of Elsevier Inc., 2011, First Edition 2007, pp. 1-2, 10.1016/B978-1-4377-2369-4.00001-9.
“Parkinson's disease misdiagnosed as stroke,” Caslake, Robert, et al. Case Reports 2009; 2009:bcr0720080558, URL= https://casereports.bmj.com/content/2009/bcr.07.2008.0558.
“Vagus Nerve Stimulation during Rehabilitative Training Improves Forelimb Strength Following Ischemic Stroke.” N. Khodoparast et al.,“Neurobiology of Disease,” Academic Press, Aug. 15, 2013, https://www.sciencedirect.com/science/article/pii/S0969996113002234, DOI: 10.1016/j.nbd.2013.08.002.
“Vagus Nerve Stimulation During Rehabilitative Training Improves Functional Recovery After Intracerebral Hemorrhage,” Seth A. Hays et al., Stroke. vol. 45, No. 10, Oct. 2014; pp. 3097-3100, 45(10): 3097-3100, DOI: 10.1161/STROKEAHA.114.006654.
“Vagus Nerve Stimulation During Rehabilitative Training Improves Forelimb Recovery After Chronic Ischemic Stroke in Rats.” Khodaparast, Navid, et al., Neurorehabilitation and Neural Repair, vol. 30, No. 7, Apr. 2015, pp. 676-684, DOI: 10.1177/1545968315616494.
“Vagus Nerve Stimulation during Rehabilitative Training Enhances Recovery of Forelimb Function after Ischemic Stroke in Aged Rats.” Hays, Seth A., et al., Neurobiology of Aging, vol. 43, 2016, pp. 111-118, DOI:10.1016/j.neurobiolaging.2016.03.030.
“The Timing and Amount of Vagus Nerve Stimulation during Rehabilitative Training Affect Poststroke Recovery of Forelimb Strength.” Hays, Seth A., et al., NeuroReport, vol. 25, No. 9, 2014, pp. 682-688, DOI:10.1097/wnr.0000000000000154.
“Forelimb Training Drives Transient Map Reorganization in Ipsilateral Motor Cortex.” Pruitt, David T., et al., Behavioural Brain Research, vol. 313, 2016, pp. 10-16, DOI: 10.1016/j.bbr.2016.07.005.
“Reorganization of Motor Cortex by Vagus Nerve Stimulation Requires Cholinergic Innervation.” Hulsey, Daniel R., et al., Brain Stimulation, vol. 9, No. 2, 2016, pp. 174-181, DOI: 10.1016/j.brs.2015.12.007.
“Vagus Nerve Stimulation Delivered with Motor Training Enhances Recovery of Function after Traumatic Brain Injury.” Pruitt, David T., et al., Journal of Neurotrauma, vol. 33, No. 9, 2016, pp. 871-879, DOI: 10.1089/neu.2015.3972.
“Vagus Nerve Stimulation Paired with Tactile Training Improved Sensory Function in a Chronic Stroke Patient.” Kilgard, Michael P., et al., NeuroRehabilitation, vol. 42, No. 2, Dec. 2018, pp. 159-165, DOI: 10.3233/nre-172273.
“Vagus Nerve Stimulation Enhances Stable Plasticity and Generalization of Stroke Recovery.” Meyers, Eric C., et al., Stroke, vol. 49, No. 3, 2018, pp. 710-717, DOI: 10.1161/strokeaha.117.019202.
“The Neuroscience Peer Review Consortium” and “Peer Review,” “Neurobiology of Disease,” URL = https://www.elsevier.com/journals/neurobiology-of-disease/0969-9961/guide-for-authors.
“Reversing pathological neural activity using targeted plasticity,” Navzer D. Engineer, Michael P. Kilgard, et al., Nature 470, 101-104, Feb. 2, 2011, URL = http://www.nature.com/doifinder/10.1038/nature09656, DOI: 10.1038/nature09656.
“Harnessing Plasticity to Reset Dysfunctional Neurons,” Andres M. Lozano, M.D., Ph.D., New England Journal of Medicine (NEJM), Apr. 7, 2011, vol. 364, Issue 14, pp. 1367-1368, DOI: 10.1056/NEJMcibr1100496.
“Epidural Electrical Stimulation for Stroke Rehabilitation: Results of the Prospective, Multicenter, Randomized, Single-Blinded Everest Trial,” Levy, Robert M., et al., Neurorehabilitation and Neural Repair, 2016, vol. 30(2), pp. 107-119, DOI: 10.1177/1545968315575613, URL = https://journals.sagepub.com/doi/full/10.1177/1545968315575613.
“Assignment abstract of title for Application 11255187,” assignors Firlik et al., URL = https://assignment.uspto.gov/patent/index.html#/patent/search/resultAbstract?id=11255187&type=applNum.
“Northstar Neuroscience's Renova Cortical Stimulation System (1999-2009),” David Prutchi, Ph.D., implantable-device.com, Dec. 22, 2011, URL= http://www.implantable-device.com/2011/12/22/northstar-neurosciences-renova-cortical-stimulation-system/.
“Definition of pivotal, Merriam-Webster,” Apr. 25, 2009, merriam-webster.com, URL = https://www.merriam-webster.com/dictionary/pivotal. by way of Wayback Machine, URL = https://web.archive.org/web/20090425064511/https://www.merriam-webster.com/dictionary/pivotal.
“Neurobionics: the biomedical engineering of neural prostheses,” Shepherd, R. K. (Editor), 2016, p. 288, John Wiley & Sons, Hoboken, NJ.
“Effects of Stroke,” Columbia University Department of Neurology (hereinafter, “CUDN”), Feb. 2, 2016, URL = http://www.columbianeurology.org/neurology/staywell/document.php?id=33910, by way of Wayback Machine, URL = https://web.archive.org/web/20160202235011/http://www.columbianeurology.org/neurology/staywell/document.php?id=33910.
“Safety, Feasibility, and Efficacy of Vagus Nerve Stimulation Paired With Upper-Limb Rehabilitation After Ischemic Stroke,” Dawson, J. et al., (Jan. 2016), “Stroke,” vol. 47, Issue 1, pp. 143-150, DOI: 10.1161/STROKEAHA.115.010477.
“Clinical Trials and Human Subject Protection,” FDA, Oct. 7, 2019, URL= https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection.
“Learn About Clinical Trials,” ClinicalTrials.gov, Oct. 7, 2019, URL= https://clinicaltrials.gov/ct2/about-studies/learn.
“Transcutaneous Auricular Vagus Nerve Stimulation with Concurrent Upper Limb Repetitive Task Practice for Poststroke Motor Recovery: A Pilot Study,” Redgrave et al., “Journal of Stroke and Cerebrovascular Diseases,” Mar. 24, 2018, https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.02.056.
“Transcutaneous Vagus Nerve Stimulation Combined with Robotic Rehabilitation Improves Upper Limb Function after Stroke,” Capone et al., “Neural Plasticity,” vol. 2017, Article ID 7876507, Dec. 10, 2017. https://doi.org/10.1155/2017/7876507.
Porter B, Khodaparast N, Fayyaz T, et al. “Repeatedly Pairing Vagus Nerve Stimulation with a Movement Reorganizes Primary Motor Cortex,” “Cerebral Cortex” 2012;22:2365-2374, doi: 10.1093/cercor/bhr316.
“Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke (tVNS),” Volpe et al., ClinicalTrials.gov, Identifier NCT03592745, Jul. 19, 2018, https://clinicaltrials.gov/ct2/show/study/NCT03592745?term=Vagus+nerve+stimulation&draw=2&rank=1.
“Targeting Plasticity with Vagus Nerve Stimulation to Treat Neurological Disease,” Hays, S. A., Rennaker, R. L., & Kilgard, M. P., “Progress in Brain Research,” vol. 207, Dec. 2, 2013, pp. 275-299, doi: 10.1016/b978-0-444-63327-9.00010-2.
“Vagus Nerve Stimulation Delivered During Motor Rehabilitation Improves Recovery in a Rat Model of Stroke,” Khodaparast, Navid, et al., Neurorehabilitation and Neural Repair, vol. 28, No. 7, 2014, pp. 698-706, doi:10.1177/1545968314521006.
“Types of peer review (Single blind review),” “Neurobiology of Disease,” URL = https://www.elsevier.com/reviewers/what-is-peer-review.
Related Publications (1)
Number Date Country
20170224994 A1 Aug 2017 US
Provisional Applications (4)
Number Date Country
61149387 Feb 2009 US
61086116 Aug 2008 US
61078954 Jul 2008 US
61077648 Jul 2008 US
Continuations (2)
Number Date Country
Parent 14809781 Jul 2015 US
Child 15496766 US
Parent 12485040 Jun 2009 US
Child 14809781 US